Therefore, the stimulatory effect of osteoblasts treated with ISO on migration and invasion of prostate cancer cells, which is independent of promoting proliferation, must occur via stimulation of the β2AR in osteoblasts, rather than via a direct effect on prostate cancer cells. The gene discussed is ADRB2; the disease is prostate carcinoma.